{
  "id": "ngn_sa_mission500_1",
  "caseId": "MISSION-500-119-1771349733794",
  "itemType": "standalone",
  "questionType": "selectAll",
  "difficulty": 5,
  "topic": "Endocrine/HHS",
  "questionText": "The nurse is caring for a client in the intensive care unit admitted for Hyperosmolar Hyperglycemic State (HHS). The nurse has just received the 0800 (08:00) laboratory results and a new ECG tracing. Based on the clinical data provided, which actions should the nurse take immediately? Select all that apply.",
  "tabs": [
    {
      "id": "tab1",
      "title": "Nurses' Notes",
      "content": "0600 (06:00) (ED): Client is a 58-year-old male with a history of Type 2 Diabetes, Hypertension, and Stage 3 Chronic Kidney Disease. He was brought to the ED by a neighbor who found him confused and lethargic. The neighbor reports the client lost his job two months ago, has had difficulty affording medications, and has had vomiting and diarrhea for 3 days. Client is lethargic, arouses to painful stimuli, not oriented to time or place. Skin is warm, dry, with poor turgor. Mucous membranes are dry.\n\n0800 (08:00) (ICU): Client admitted to ICU. Two liters of 0.9% sodium chloride have been infused since admission. A regular insulin infusion was initiated at 0700 (07:00). Client remains lethargic, oriented only to person. Urine output 40 mL in the past hour."
    },
    {
      "id": "tab2",
      "title": "Vital Signs",
      "content": {
        "type": "table",
        "header": [
          "Time",
          "Heart Rate (bpm)",
          "Blood Pressure",
          "Respiratory Rate (breaths/min)",
          "SpO2 (%)"
        ],
        "rows": [
          [
            "0600 (06:00) (ED)",
            "128",
            "88/50",
            "22",
            "95% on room air"
          ],
          [
            "0700 (07:00) (ED)",
            "115",
            "94/58",
            "20",
            "96% on room air"
          ],
          [
            "0800 (08:00) (ICU)",
            "122",
            "90/54",
            "24",
            "94% on room air"
          ]
        ]
      }
    },
    {
      "id": "tab3",
      "title": "Laboratory Results",
      "content": {
        "type": "table",
        "header": [
          "Lab Test",
          "Result (0600)",
          "Result (0800)",
          "Reference Range"
        ],
        "rows": [
          [
            "Glucose",
            "950 mg/dL",
            "780 mg/dL",
            "70-110 mg/dL"
          ],
          [
            "Potassium (K+)",
            "3.6 mEq/L",
            "2.4 mEq/L",
            "3.5-5.0 mEq/L"
          ],
          [
            "Sodium (Na+)",
            "148 mEq/L",
            "146 mEq/L",
            "135-145 mEq/L"
          ],
          [
            "BUN",
            "98 mg/dL",
            "95 mg/dL",
            "10-20 mg/dL"
          ],
          [
            "Creatinine",
            "3.4 mg/dL",
            "3.3 mg/dL",
            "0.6-1.2 mg/dL"
          ],
          [
            "Serum Osmolality",
            "365 mOsm/kg",
            "Not Available",
            "275-295 mOsm/kg"
          ],
          [
            "Troponin I",
            "Not Available",
            "<0.02 ng/mL",
            "<0.04 ng/mL"
          ]
        ]
      }
    },
    {
      "id": "tab4",
      "title": "Diagnostic Findings",
      "content": "Electrocardiogram (ECG) at 0800 (08:00): Sinus tachycardia with a rate of 122 bpm. Flattened T-waves, prominent U waves, and frequent premature ventricular contractions (PVCs) are noted."
    },
    {
      "id": "tab5",
      "title": "Medication Administration Record",
      "content": {
        "type": "table",
        "header": [
          "Medication",
          "Dose",
          "Route",
          "Frequency/Instructions"
        ],
        "rows": [
          [
            "0.9% Sodium Chloride",
            "500 mL/hr",
            "IV",
            "Continuous Infusion"
          ],
          [
            "Regular Insulin Infusion",
            "7 units/hr",
            "IV",
            "Continuous Infusion (Client weight 70 kg)"
          ],
          [
            "Potassium Chloride",
            "20 mEq/L",
            "IV",
            "To be added to each liter of IV fluid"
          ],
          [
            "Lisinopril",
            "10 mg",
            "PO",
            "Daily (On Hold)"
          ],
          [
            "Metformin",
            "1000 mg",
            "PO",
            "Twice Daily (On Hold)"
          ]
        ]
      }
    }
  ],
  "options": [
    {
      "id": "opt4",
      "text": "Administer a 500 mL bolus of 0.9% sodium chloride."
    },
    {
      "id": "opt3",
      "text": "Place the client on continuous cardiac monitoring."
    },
    {
      "id": "opt5",
      "text": "Notify the healthcare provider of the new findings."
    },
    {
      "id": "opt1",
      "text": "Stop the insulin infusion."
    },
    {
      "id": "opt6",
      "text": "Prepare to administer a high-concentration potassium chloride infusion."
    },
    {
      "id": "opt2",
      "text": "Increase the insulin infusion rate to lower glucose faster."
    }
  ],
  "correctAnswer": [
    "opt1",
    "opt3",
    "opt5",
    "opt6"
  ],
  "rationale": "The central clinical problem is life-threatening hypokalemia (K+ 2.4 mEq/L) resulting from the treatment of HHS. In HHS, hyperglycemia leads to osmotic diuresis, causing dehydration and electrolyte loss, including potassium. Insulin administration further exacerbates hypokalemia by promoting the intracellular shift of potassium. The combination of IV fluids and insulin has shifted potassium from the extracellular to the intracellular space, causing the serum potassium to drop from a low-normal 3.6 mEq/L to a critical 2.4 mEq/L. This is confirmed by the ECG changes (flattened T-waves, prominent U waves, PVCs), which indicate severe cardiac muscle irritability and a high risk for lethal arrhythmias such as ventricular tachycardia or fibrillation. The client's worsening vital signs (tachycardia, hypotension) are likely due to cardiac instability from hypokalemia rather than just hypovolemia. The nurse's immediate priority is to stop the cause of the potassium shift (insulin) and urgently correct the potassium deficit to prevent cardiac arrest.",
  "answerBreakdown": [
    {
      "optionId": "opt1",
      "isCorrect": true,
      "justification": "Correct (+). This is the most critical immediate action. The insulin infusion is driving potassium into the cells, worsening the life-threatening hypokalemia (K+ 2.4 mEq/L). Continuing the infusion poses an imminent risk of fatal cardiac arrhythmia. This is a \"SAFETY STOP\" moment where the nurse must recognize the danger and halt the intervention causing it. The pathophysiology behind this is that insulin stimulates the Na+/K+-ATPase pump, which actively transports potassium into cells, leading to a decrease in serum potassium levels. In the context of HHS, where potassium stores are already depleted due to osmotic diuresis, this effect is amplified."
    },
    {
      "optionId": "opt2",
      "isCorrect": false,
      "justification": "Incorrect (-). This action is extremely dangerous and could be fatal. Although the glucose is still high, increasing the insulin would accelerate the intracellular shift of potassium, critically worsening the hypokalemia and likely precipitating ventricular tachycardia or fibrillation. The priority has shifted from hyperglycemia to electrolyte imbalance. Increasing the insulin would further stimulate the Na+/K+-ATPase pump, exacerbating the hypokalemia. The already compromised cardiac function due to low potassium levels makes the patient highly susceptible to life-threatening arrhythmias."
    },
    {
      "optionId": "opt3",
      "isCorrect": true,
      "justification": "Correct (+). The ECG already shows significant signs of cardiac instability (U waves, frequent PVCs) secondary to severe hypokalemia. Continuous cardiac monitoring is essential to detect and treat any lethal arrhythmias immediately as they occur. Hypokalemia affects the repolarization phase of the cardiac action potential, leading to prolonged QT intervals, U waves, and increased risk of arrhythmias. Continuous monitoring allows for immediate detection of these changes and prompt intervention."
    },
    {
      "optionId": "opt4",
      "isCorrect": false,
      "justification": "Incorrect (-). While the client is still likely volume-depleted (hypotension, tachycardia), the most immediate life threat is cardiac arrest from hypokalemia. Administering a fluid bolus without potassium would further dilute the serum potassium concentration, potentially worsening the situation. The priority is potassium correction, not a fluid bolus at this specific moment. While fluid resuscitation is important in HHS, it should be done cautiously in the presence of severe hypokalemia, as it can further dilute the potassium concentration and exacerbate cardiac instability. Potassium replacement should precede or occur concurrently with aggressive fluid resuscitation."
    },
    {
      "optionId": "opt5",
      "isCorrect": true,
      "justification": "Correct (+). The nurse has identified a critical, life-threatening situation (K+ 2.4, ECG changes) that requires immediate medical intervention beyond the current orders. The provider must be notified immediately to obtain orders for aggressive intravenous potassium replacement. Prompt communication ensures timely intervention and prevents further deterioration of the patient's condition. The healthcare provider needs to be informed to order appropriate potassium replacement therapy and address the underlying causes of hypokalemia."
    },
    {
      "optionId": "opt6",
      "isCorrect": true,
      "justification": "Correct (+). The nurse should anticipate the provider's orders. A serum potassium of 2.4 mEq/L with ECG changes requires urgent and aggressive replacement, typically with a higher concentration potassium infusion (e.g., 20-40 mEq/hr via a central line) than what is currently ordered (20 mEq/L of maintenance fluid). Preparing for this intervention is a correct and proactive nursing action. Rapid potassium replacement is crucial to restore normal cardiac function and prevent life-threatening arrhythmias. High-concentration potassium infusions require careful monitoring and administration to avoid hyperkalemia and associated complications."
    }
  ],
  "sbar": {
    "situation": "A 58-year-old male with a history of Type 2 Diabetes, Hypertension, and Stage 3 Chronic Kidney Disease is in the ICU for Hyperosmolar Hyperglycemic State (HHS).",
    "background": "The client was admitted to the ED at 0600 (06:00) confused and lethargic with a history of vomiting and diarrhea for 3 days. He has had difficulty affording medications due to job loss. He has received two liters of 0.9% sodium chloride, and a regular insulin infusion was initiated at 0700 (07:00).",
    "assessment": "At 0800 (08:00), the client remains lethargic, oriented only to person. Vital signs: HR 122 bpm, BP 90/54, RR 24, SpO2 94% on room air. Lab results: Glucose 780 mg/dL, K+ 2.4 mEq/L, Na+ 146 mEq/L, BUN 95 mg/dL, Creatinine 3.3 mg/dL. ECG: Sinus tachycardia with flattened T-waves, prominent U waves, and frequent PVCs.",
    "recommendation": "I recommend stopping the insulin infusion immediately, placing the client on continuous cardiac monitoring, notifying the healthcare provider of the new findings, and preparing to administer a high-concentration potassium chloride infusion due to severe hypokalemia and ECG changes. I also recommend discussing the need for central line placement with the provider if high-dose potassium replacement is required."
  },
  "clinicalPearls": [
    "Severe hypokalemia (K+ < 2.5 mEq/L) can cause life-threatening cardiac arrhythmias, including ventricular tachycardia and fibrillation.",
    "Insulin administration shifts potassium from the extracellular to the intracellular space, which can worsen hypokalemia, especially in patients with HHS or DKA.",
    "ECG changes associated with hypokalemia include flattened T-waves, prominent U waves, and premature ventricular contractions (PVCs).",
    "In HHS, the priority is often fluid resuscitation and insulin administration, but electrolyte imbalances, particularly hypokalemia, must be closely monitored and corrected to prevent adverse outcomes.",
    "When a patient exhibits signs of severe hypokalemia, the nurse should immediately stop the insulin infusion, place the patient on continuous cardiac monitoring, notify the healthcare provider, and prepare to administer a high-concentration potassium chloride infusion.",
    "Consider the patient's renal function when administering potassium, as impaired kidney function can lead to hyperkalemia.",
    "Central line placement may be necessary for high-concentration potassium infusions to prevent phlebitis and ensure safe administration."
  ],
  "sentinelStatus": "healed_v2026_v8"
}